Mostrar el registro sencillo del ítem

dc.contributor.author
Keller, Kirsten  
dc.contributor.author
Maass, Martina  
dc.contributor.author
Dizayee, Sara  
dc.contributor.author
Leiss, Veronika  
dc.contributor.author
Annala, Suvi  
dc.contributor.author
Köth, Jessica  
dc.contributor.author
Seemann, Wiebke K.  
dc.contributor.author
Müller Ehmsen, Jochen  
dc.contributor.author
Mohr, Klaus  
dc.contributor.author
Nürnberg, Bernd  
dc.contributor.author
Engelhardt, Stefan  
dc.contributor.author
Herzig, Stefan  
dc.contributor.author
Birnbaumer, Lutz  
dc.contributor.author
Matthes, Jan  
dc.date.available
2018-03-05T19:26:52Z  
dc.date.issued
2015-12  
dc.identifier.citation
Keller, Kirsten; Maass, Martina; Dizayee, Sara; Leiss, Veronika; Annala, Suvi; et al.; Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice; Oxford University Press; Cardiovascular Research; 108; 3; 12-2015; 348-356  
dc.identifier.issn
0008-6363  
dc.identifier.uri
http://hdl.handle.net/11336/37874  
dc.description.abstract
Aims Inhibitory G (Gi) proteins have been proposed to be cardioprotective. We investigated effects of Gαi2 knockout on cardiac function and survival in a murine heart failure model of cardiac β1-adrenoceptor overexpression. Methods and results β1-transgenic mice lacking Gαi2 (β1-tg/Gαi2 -/-) were compared with wild-type mice and littermates either overexpressing cardiac β1-adrenoceptors (β1-tg) or lacking Gαi2 (Gαi2 -/-). At 300 days, mortality of mice only lacking Gαi2 was already higher compared with wild-type or β1-tg, but similar to β1-tg/Gαi2 -/-, mice. Beyond 300 days, mortality of β1-tg/Gαi2 -/- mice was enhanced compared with all other genotypes (mean survival time: 363 ± 21 days). At 300 days of age, echocardiography revealed similar cardiac function of wild-type, β1-tg, and Gαi2 -/- mice, but significant impairment for β1-tg/Gαi2 -/- mice (e.g. ejection fraction 14 ± 2 vs. 40 ± 4% in wild-type mice). Significantly increased ventricle-to-body weight ratio (0.71 ± 0.06 vs. 0.48 ± 0.02% in wild-type mice), left ventricular size (length 0.82 ± 0.04 vs. 0.66 ± 0.03 cm in wild types), and atrial natriuretic peptide and brain natriuretic peptide expression (mRNA: 2819 and 495% of wild-type mice, respectively) indicated hypertrophy. Gαi3 was significantly up-regulated in Gαi2 knockout mice (protein compared with wild type: 340 ± 90% in Gαi2 -/- and 394 ± 80% in β1-tg/Gαi2 -/-, respectively). Conclusions Gαi2 deficiency combined with cardiac β1-adrenoceptor overexpression strongly impaired survival and cardiac function. At 300 days of age, β1-adrenoceptor overexpression alone had not induced cardiac hypertrophy or dysfunction while there was overt cardiomyopathy in mice additionally lacking Gαi2. We propose an enhanced effect of increased β1-adrenergic drive by the lack of protection via Gαi2. Gαi3 up-regulation was not sufficient to compensate for Gαi2 deficiency, suggesting an isoform-specific or a concentration-dependent mechanism.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Oxford University Press  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Adrenergic Receptor  
dc.subject
Cardiomyopathy  
dc.subject
Cardioprotection  
dc.subject
Heart Failure  
dc.subject
Inhibitory G Protein  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-03-02T17:33:01Z  
dc.journal.volume
108  
dc.journal.number
3  
dc.journal.pagination
348-356  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Oxford  
dc.description.fil
Fil: Keller, Kirsten. Universitat Zu Köln; Alemania  
dc.description.fil
Fil: Maass, Martina. University Hospital of Cologne; Alemania  
dc.description.fil
Fil: Dizayee, Sara. Universitat Zu Köln; Alemania  
dc.description.fil
Fil: Leiss, Veronika. Eberhard Karls University Hospitals and Clinics; Alemania  
dc.description.fil
Fil: Annala, Suvi. Universitat Zu Köln; Alemania  
dc.description.fil
Fil: Köth, Jessica. Universitat Zu Köln; Alemania  
dc.description.fil
Fil: Seemann, Wiebke K.. Universitat Zu Köln; Alemania  
dc.description.fil
Fil: Müller Ehmsen, Jochen. Asklepios Klinik Altona; Alemania  
dc.description.fil
Fil: Mohr, Klaus. Universitaet Bonn; Alemania  
dc.description.fil
Fil: Nürnberg, Bernd. Eberhard Karls University Hospitals and Clinics; Alemania  
dc.description.fil
Fil: Engelhardt, Stefan. Universitat Technical Zu Munich; Alemania  
dc.description.fil
Fil: Herzig, Stefan. Universitat Zu Köln; Alemania  
dc.description.fil
Fil: Birnbaumer, Lutz. National Institutes of Health; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Matthes, Jan. Universitat Zu Köln; Alemania  
dc.journal.title
Cardiovascular Research  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1093/cvr/cvv235  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/cardiovascres/article/108/3/348/557401